tiprankstipranks
Titan Pharmaceuticals (TTNP)
NASDAQ:TTNP
US Market

Titan Pharmaceuticals (TTNP) Income Statement

Compare
791 Followers

Titan Pharmaceuticals Income Statement

Last quarter (Q3 2024), Titan Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Titan Pharmaceuticals's net income was $-763.00K. See Titan Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 184.00K$ 60.00K$ 1.53M$ 4.84M$ 3.61M
Gross Profit
$ 72.00K$ -136.00K$ 1.33M$ 4.37M$ 2.32M
Operating Expenses
$ 7.28M$ 10.29M$ 10.68M$ 11.72M$ 19.17M
Depreciation and Amortization
$ 112.00K$ 196.00K$ 221.00K$ 292.00K$ 244.00K
EBITDA
$ -7.17M$ -10.04M$ -9.13M$ -7.06M$ -6.28M
Operating Income
$ -7.28M$ -10.23M$ -9.35M$ -7.35M$ -16.84M
Other Income/Expenses
$ 1.71M$ 29.00K$ 578.00K$ -56.00K$ 386.00K
Pretax Income
$ -5.57M$ -10.21M$ -8.78M$ -7.41M$ -16.46M
Net Income
$ -5.57M$ -10.18M$ -8.11M$ -20.73M$ -16.09M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -7.41$ -15.15$ -16.68$ -109.88$ -12.60K
Diluted EPS
$ -7.41$ -15.15$ -16.68$ -109.88$ -12.60K
Weighted Average Shares Outstanding
752.00K 671.70K 486.50K 188.65K-
Weighted Average Shares Outstanding (Diluted)
752.00K 671.70K 486.50K 188.65K-
Currency in USD

Titan Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis